SecBot SecBot
DEFA14A ·Filed Jun 29, 2026

ANAB

ANAPTYSBIO, INC
NEUTRAL
Impact 2/10
Horizonweeks Processed4mo ago SEC0001193125-26-288431
Proxy solicitation materials
Actionable Insight • Neutral

This is a routine proxy reminder, no material new information. The equity plan amendment could be dilutive if it adds significant share reserves, but details are not in this filing. Monitor the definitive proxy statement for share counts. The meeting is six weeks away; no immediate trading catalyst.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$67.50
T+0 close · Jun 29, 2026 · via day close
Latest settled
−24.79%
T+60 · $50.77
Vs SPY
−28.35%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 30 $67.50entry
  2. T+1 · 5mo ago −3.07%α −2.93% · $65.43
  3. T+5 · 4mo ago −7.69%α −8.29% · $62.31
  4. T+20 · 4mo ago −20.58%α −19.55% · $53.61
  5. T+60 · 8w ago −24.79%α −28.35% · $50.77
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

AnaptysBio filed definitive additional proxy soliciting materials (DEFA14A) for its August 11, 2026 Annual Meeting. The board recommends voting FOR all four proposals: electing two Class III directors (Hollings Renton and John P. Schmid), ratifying KPMG LLP as auditor, approving say-on-pay, and amending the 2017 Equity Incentive Plan. This is a routine management proxy solicitation with no contested matters or activist involvement.

Key Financial Metrics

Meeting
2026-08-11

Key Facts

  • Annual Meeting scheduled for August 11, 2026 at 9:00 AM Pacific Time
  • Record date for stockholders is June 22, 2026
  • Board recommends FOR votes on all four proposals
  • Proposals include election of two Class III directors, auditor ratification, say-on-pay vote, and equity plan amendment
  • Director nominees: Hollings Renton and John P. Schmid
  • KPMG LLP proposed as independent auditor for fiscal year ending June 30, 2027
  • This is definitive additional materials (DEFA14A), not the definitive proxy statement itself

Financial Impact

No financial figures disclosed in this filing. The equity plan amendment may involve share reserve increases but no amounts are stated.

equity_compensationshareholder_voting

Risk Factors

  • Equity plan amendment could be dilutive if share reserve increase is large
  • Say-on-pay vote may receive low support if compensation practices are controversial, though no opposition has been filed

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (17 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-288431
Document: 0001193125-26-288431-index-headers.html0001193125-26-288431
Document: 0001193125-26-288431-index.html0001193125-26-288431
Document: 0001193125-26-288431.txt0001193125-26-288431

Track record

28 reports on ANAB

Performance horizon

10 of 19 bullish or bearish reports moved the stock their way by T+1. Best: +41.26% at T+60 after the Mar 3, 2026 report. 13 of 19 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $46.25 Now $45.73 −1.12% settles Nov 17
  2. Nov 12, 20264d ago Press Release Bearish 4/10 Entry $46.25 to $45.73 Now $45.73 +1.12% ▲ +1.12% −0.79% vs SPY
  3. Nov 6, 202610d ago Institutional Cluster Neutral 2/10 Entry $46.45 to $47.97 Now $45.73 −1.55% ▲ +3.27% +0.91% vs SPY
  4. Sep 21, 20268w ago Press Release Neutral 5/10 Entry $53.92 to $50.77 Now $45.73 −15.19% ▼ −5.84% −5.12% vs SPY
  5. Aug 12, 202613w ago Institutional Cluster Bullish 5/10 Entry $56.02 to $58.47 Now $45.73 −18.37% ▲ +4.37% +4.57% vs SPY
  6. Jun 29, 202620w ago 144 Bearish 6/10 Entry $67.50 to $65.43 Now $45.73 +32.25% ▲ +3.07% +2.93% vs SPY
  7. Jun 29, 202620w ago DEFA14A Neutral 2/10 Viewing Entry $67.50 to $65.43 Now $45.73 −32.25% ▼ −3.07% −2.93% vs SPY
  8. Jun 26, 202620w ago 144 Bearish 6/10 Entry $65.97 to $67.50 Now $45.73 +30.68% ▼ −2.32% −1.54% vs SPY
  9. Jun 22, 202621w ago 8-K Neutral 2/10 Entry $59.43 to $58.48 Now $45.73 −23.05% ▼ −1.60% −1.55% vs SPY
  10. Jun 17, 202621w ago 144 Bearish 5/10 Entry $57.51 to $59.99 Now $45.73 +20.48% ▼ −4.31% −4.63% vs SPY
Showing 10 of 28

US Market Status

Market Closed · Opens in 6h 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 3, 2026